Video: Pharmaspectra’s Chief Medical Officer discusses measurement of Medical Affairs impact
Pharmaspectra’s CMO discusses how Medical Affairs teams are using Share of Scientific Voice™ (SoSV) to optimize product launch planning.
Resources: Features
![]()
![]()
VIDEO: Transforming product development in rare disease
![]()
Rare Disease webinar
![]()
“The reality of different types of users requires tailored support, not a ‘one-size-fits-all’ approach.”
![]()
Large MSL survey reveals opportunities to leverage measurement in order to optimize impact
![]()
How Pharmaspectra’s scientific Centers of Excellence (CoE) analysis can transform your strategy
![]()
Pharmaspectra Chair interviewed by The Pharma Letter – ‘Ever-improving data analytics drive better patient outcomes.’
![]()
Interview for the MSL Society Conference – Our VP Medical Affairs, Joseph Laudano, discusses “The role of experience in the ability to adapt”.
![]()
Pharmaspectra interview: What makes a difference when identifying and engaging experts in rare disease?
![]()
Pharmaspectra achieves unprecedented growth in 2021, with 27 new clients and reveals plans to expand presence in the US and Europe
![]()
There’s more Rare Disease data than you probably realize
![]()
Video: Dr Tennigkeit, UCB Biosciences, discusses the importance of KOL identification and engagement in Rare Diseases
![]()
MSL Journal – Pharmaspectra’s Joseph Laudano discusses the use of analytics to measure the impact of engagement activities
Do You Really Know all the Top Experts in Rare Diseases?
Are You Seeing All the Science You Need, When You Need It?
The Increasing Importance of Generating and Accessing Real-World Evidence
To maximize KOL impact, Medical Affairs needs a digital strategy too
Pharmaspectra’s global meetings coverage
Identifying predatory journals
The role of medical affairs in healthcare
When real-world evidence and randomized clinical trials disagree
Conference proceedings key to faster dissemination of findings
The dual role of conference papers in biomedical research
Top 3 reasons why conference literature is so important
What data tips the scale for a “go” decision among care providers?
